Related Experiment Video
Updated: Apr 1, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Cystathionine Levels in Patients With Huntington Disease
N A Aziz1, W Onkenhout2, H J Kerstens2
1Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.
Insights
Plasma and urine cystathionine levels did not differ between early-stage Huntington disease (HD) patients and controls. These findings suggest cystathionine is not a useful biomarker for HD progression.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Huntington disease (HD) is associated with reduced cystathionine γ-lyase (CSE) activity.
- CSE is crucial for cysteine synthesis from cystathionine.
Purpose of the Study:
- To investigate if blood and urine cystathionine levels are elevated in HD patients.
- To determine if cystathionine levels correlate with HD progression.
Main Methods:
- Measured cystathionine and 22 other amino acids in plasma and urine.
- Included nine early-stage HD patients and nine matched controls.
Main Results:
- No significant differences in plasma or urine cystathionine concentrations were observed between HD patients and controls.
- No significant differences were found for any other measured amino acids.
Conclusions:
- Plasma and urine cystathionine levels do not change in early-stage HD.
- Cystathionine is unlikely to serve as a reliable biomarker for Huntington disease.
Background:
Recently a profound depletion of cystathionine γ-lyase (CSE), the principal enzyme involved in the generation of cysteine from cystathionine, was shown in Huntington disease (HD) patients and several transgenic HD mouse models. We therefore hypothesized that blood and urine cystathionine levels may be increased in HD patients and that this increase might correlate with disease progression.
Methods:
We measured concentrations of cystathionine as well as 22 other amino acids in fasting plasma and 24-h urine samples of nine early-stage HD patients and nine age, sex, and body mass index matched controls.
Results:
There were no significant differences in the plasma or urine concentrations of cystathionine or any other amino acid between HD patients and controls.
Conclusion:
We found no evidence for changes in plasma or urine concentrations of cystathionine in early-stage HD patients. Therefore, cystathionine levels are unlikely to be useful as a state biomarker in HD.
More Related Videos
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lysosomal Hydrolases
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test